Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Feb 1;67(1):18.1.1-18.1.22.
doi: 10.1002/0471140856.tx1801s67.

Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment

Affiliations
Review

Associating Changes in the Immune System with Clinical Diseases for Interpretation in Risk Assessment

Jamie C DeWitt et al. Curr Protoc Toxicol. .

Abstract

This overview is an update of the unit originally published in 2004. While the basic tenets of immunotoxicity have not changed in the past 10 years, several publications have explored the application of immunotoxicological data to the risk assessment process. Therefore, the goal of this unit is still to highlight relationships between xenobiotic-induced immunosuppression and risk of clinical diseases progression. In immunotoxicology, this may require development of models to equate moderate changes in markers of immune functions to potential changes in incidence or severity of infectious diseases. For most xenobiotics, exposure levels and disease incidence data are rarely available, and safe exposure levels must be estimated based on observations from experimental models or human biomarker studies. Thus, it is important to establish a scientifically sound framework that allows accurate and quantitative interpretation of experimental or biomarker data in the risk assessment process.

Keywords: immunosuppression; immunotoxicity; xenobiotic exposure.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in the onset, course, and outcome of infectious disease. Schematic shows factors that may influence infectious disease susceptibility.
Figure 2
Figure 2
The association between psychological stress and reported symptoms of upper respiratory illness following infection with an influenza A virus. Adapted from Cohen et al. (1999).
Figure 3
Figure 3
Pneumococcal vaccine responses in elderly caregivers, shown as antibody titer over the 6‐month period following immunization. Controls are age‐matched noncaregivers. Adapted from Glaser et al. (2000) with permission.
Figure 4
Figure 4
Timeline of infections after hematopoietic stem cell transplant (HSCT). With the exception of bacterial infections, prophylaxis is typically given for high risk infections. Adapted from O'Shea and Humar, 2013.

Similar articles

Cited by

References

    1. Ahmed, S. , Shapiro, N.L. , and Bhattacharyya, N. 2014. Incremental health care utilization and costs for acute otitis media in children. Laryngoscope 124:301‐305. doi: 10.1002/lary.24190. - DOI - PubMed
    1. ALA (American Lung Association) . 2010a. Trends in pneumonia and influenza morbidity and mortality. Am. Lung Assoc. Res. Program Serv. Epidemiol. Stat. Unit. 2010. Washington, D.C.
    1. ALA (American Lung Association) . 2010b. Influenza and pneumonia: State of lung disease in diverse communities. Washington, D.C.
    1. Ambruso, D.R. , Bentwood, B. , Henson, P.M. , and Johnston, R.B. Jr. 1984. Oxidative metabolism of cord blood neutrophils: Relationship to content and degranulation of cytoplasmic granules. Pediatr. Res. 18:1148‐1153. doi: 10.1203/00006450-198411000-00019. - DOI - PubMed
    1. André‐Schmutz, I. , Six, E. , Bonhomme, D. , Rouiller, J. , Dal Cortivo, L. , Fischer, A. , and Cavazzana‐Calvo, M. 2009. Shortening the immunodeficient period after hematopoietic stem cell transplantation. Immunol. Res. 44:54‐60. doi: 10.1007/s12026-008-8080-7. - DOI - PubMed

Publication types

LinkOut - more resources